| Name | Nafarelin |
|---|---|
| Synonyms |
(2S)-N-(2-amino-2-oxoethyl)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-(2-methylpropyl)-8-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-[(2S)-5-oxopyrrolidin-2-yl]-3,6,9,12,15,18,21-heptaazadocosan-1-oyl}pyrrolidine-2-carboxamide (non-preferred name)
RS-94991 Luteinizing hormone-releasing factor (swine), 6-[3-(2-naphthalenyl)-D-alanine] 6-(3-(2-naphthalenyl)-d-alanine)-luteinizinghormone-releasingfactor(pig (D-2-Nal6)-LHRH Nafelin Synel Nafelin (2S)-N-(2-Amino-2-oxoethyl)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-isobutyl-8-(2-naphthylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-[(2S)-5-oxopyrrolidin-2-yl]-3,6,9,12,15,18,21-heptaazadocosan-1-oyl}pyrrolidine-2-carboxamide (non-preferred name) AI3 6-(3-(2-Naphthalenyl)-D-alanine)luteinizing Hormone-releasing Factor Nafelina [spanish] Nafelin acetate salt N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[[(2-amino-2-oxoethyl)amino]-oxomethyl]-1-pyrrolidinyl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(2-naphthalenyl)-1-oxopro Synarel C07613 Synrelina Lhrh, Ala(2-naphthyl) 6-(3-(2-naphthalenyl)-d-alanine)luteinizinghormone-releasingfactor(pig) 76-0 (Monoacetate (salt)) (D-2-NAL6)-LHRH Nacenyl Nafelin [inn:ban] 86-0 (Acetate (salt), hydrate) Nafelin Acetate, Nafelina Nafelin //BP 5-Oxo-L-Pro-L-His-L-Trp-L-Ser-L-Tyr-3-(2-naphtyl)-D-Ala-L-Leu-L-g-L-Pro-Gly-NH2 Nafelina AI314925 UNII:1X0094V6JV Nafarelin Acetate Nafeline Nasanyl RS-94991-298 Pyr-His-Trp-Ser-Tyr-D-2-Nal-Leu-g-Pro-Gly-NH2 acetate salt TIANFU-CHEM_Nafelin 76-4 Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine) PYR-HIS-TRP-SER-TYR-D-2-NAL-LEU-G-PRO-GLY-NH2 Nafelin Acetate|(D-2-Nal6)-LHRH ala(2-naphthyl)-lhr Nafareline (2S)-N-(2-Amino-2-oxoethyl)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-isobutyl-8-(2-naphthylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-[(2S)-5-oxo-2-pyrrolidinyl]-3,6,9,12,15,18,21-heptaazadocosan-1-oyl}-2-pyrrolidinecarboxamide AI3-14925 |
| Description | Nafarelin is a gonadotropin-releasing hormone (GnRH) agonist that stimulates secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Sequence: {Glp}-His-Trp-Ser-Tyr-{2-Naph-Ala}-Leu-Arg-Pro-Gly-NH2. |
|---|---|
| Related Catalog | |
| Target |
GnRH[1]. |
| In Vitro | Nafarelin is a gonadotropin-releasing hormone (GnRH) agonist that stimulates secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH)[1]. Nafarelin is used effectively in in vitro fertilisation programmes. Nafarelin is readily and rapidly absorbed following intranasal delivery, and is protected to some extent from enzymatic degradation GnRH[2]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C66H83N17O13 |
| Molecular Weight | 1322.471 |
| Exact Mass | 1321.635620 |
| PSA | 472.13000 |
| LogP | 0.89 |
| Index of Refraction | 1.711 |
| Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|